We noted you are experiencing viewing problems
- 
        
        Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
 - 
        
        Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. - 
        
        No luck yet? More tips for troubleshooting viewing issues
 - 
        
        Contact HST Support access@hstalks.com
 
- 
        Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
 - 
        For additional help, please don't hesitate to contact HST support access@hstalks.com
 
We hope you have enjoyed this limited-length demo
                    
                    This is a limited length demo talk; you may
                    
                      login or
                    
                    review methods of
                    obtaining more access.
                  
                
                
              Printable Handouts
Navigable Slide Index
- Introduction
 - Apoptosis in development
 - Delayed removal of interdigital webs
 - Anti-APO-1-induced DNA ladder
 - Synchronized apoptosis in a culture
 - The death receptors
 - Two CD95 signaling pathways
 - Necrosis versus apoptosis
 - 3D model of CD95 receptor
 - CD95 DISC formation
 - c-FLIP-L/S inhibit caspase-8 activation
 - c-FLIP-L/S inhibit CD95-mediated apoptosis
 - The CD95 signaling pathway in MCF7-Fas cells
 - The immune response
 - AICD upon TCR-restimulation
 - IL-2 initiated switch regulates apoptosis sensitivity
 - IL-2 is required for efficient apoptosis of d6 T cells
 - Influence of IL-2 on DISC formation in d6 T cells
 - Influence of IL-2 on mitochondria in d6 T cells
 - CD95 resistance and sensitivity model in T cells
 - CD28 reduces CD3 induced apoptosis
 - CD28 costimulation upregulates c-FLIP-S in ATCs
 - CD28 costimulation upregulates Bcl-xL in ATCs
 - CD28 costimulation represses CD95L promoter
 - Modulation of CD95 pathway by CD28
 - Memory markers and subclasses of memory cells
 - In vitro culture system
 - Sensitivity of long-term T cells towards apoptosis
 - Proliferation assay
 - Determination of apoptosis: a healthy control
 - Determination of apoptosis: a sepsis patient
 - Septic patients lymphocytes are resistant to CD95
 - Increased T-cell apoptosis in septic patients
 - The T cell response defines survival in sepsis
 - Why apoptosis?
 - Rodent stroke model
 - Abs for CD95L and TNF attenuate stroke damage
 - Better locomotor response of Abs-treated animals
 - Spinal cord injury and MRI diagnostics
 - Spinal cord injury model
 - MRI of injured mice
 - Apoptosis after SCI
 - Apoptosis decsreses by anti-CD95L-Ab
 - Short-term experiments
 - Swimming test
 - Summary
 - Swimming test after spinal cord injury in mice
 - Dream of a tumor immunologist
 - Killer cells meet a tumor cell
 - Chemotherapy and p53-induced apoptosis (1)
 - Mutations of the p53-gene
 - p53 mutants do not transactivate the CD95-gene
 - A model for the action of chemotherapeutic drugs
 - Chemotherapy and p53-induced apoptosis (2)
 - Tumor regression induced by anti-APO-1
 
Topics Covered
- Basics of apoptosis
 - Signalling through death receptors
 - Apoptosis in the immune system
 - Apoptosis in diseases: sepsis, stroke and spinal cord injury
 - Apoptosis and killer T cells
 - Apoptosis and p53
 - Apoptosis and cancer
 
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Krammer, P. (2007, October 1). Apoptosis in the immune system [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 4, 2025, from https://doi.org/10.69645/SZDV8392.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Peter Krammer has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.